Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human Obesity (Q61915351)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human Obesity |
clinical trial |
Statements
A Prospective Trial of Anti-TNF-Alpha Chimeric Monoclonal Antibody (Infliximab, Remicade®) on Insulin Sensitivity, Beta Cell Function and Cardiovascular Risk Profile in Insulin Resistant Human Obesity (English)
0 references
September 2005
0 references
June 2007
0 references
9
0 references
20 year
0 references
50 year
0 references